7º BioTech & eHealth - 1st April

Startups raising funds

  • ArriVent Biopharma, a biotech whose lead candidate is a mutant-specific EGFR kinase inhibitor, raised $155m in Series B funding. Sofinnova Investments and General Catalyst co-led, and were joined by Catalio Capital Management, HBM Healthcare Investments, Shanghai Healthcare Capital, Sequoia Capital China, AIHC Capital, Terra Magnum Capital Partners, Unicorn Capital Partners Limited, Infinitum Asset Management and insiders Lilly Asia Ventures, OrbiMed, Octagon Capital Advisors, Sirona Capital and Boyu/Zoo Capital. Link
  • Labviva, a Boston-based online marketplace for life science supplies, raised $20m in Series A funding. Biospring Partners led, and was joined by insiders Senator Investment Group, B Capital Group and Glasswing Ventures. Link
  • Mbiomics, a German microbiome biotech startup, raised €13m in Series A funding. MIG led, and was joined by High-Tech Gründerfonds and Bayern Kapital. Link
  • Genialis, a Houston-based computational precision medicine startup, raised $13m in Series A funding. Taiwania Capital and Debiopharm Innovation Fund co-led, and were joined by First Star Ventures, Aedalpine Venture Partners, Pikas and P5 Health Ventures. Link
  • Florence, an ER patient intake and tracking startup, raised $20m in seed funding. Thrive Capital, GV and Salesforce Ventures co-led, and were joined by Vast Ventures, BoxGroup and Atento Capital. Link

M&A and Private equity deals

  • CVS (NYSE: CVS) said it expects to close its $8b acquisition of SignifyHealth (NYSE: SGFY) this week. Sellers include New Mountain Capital. Link
  • JounceTherapeutics (Nasdaq: JNCE) terminated a merger agreement with Redx Pharma (LSE: REDX), in order to be acquired for around $96m by Concentra Biosciences, a privately held company backed by Tang Capital Partners. Link
  • Inato, a Guilford, Conn.-based clinical trials marketplace, raised $20m in Series A2 funding. Cathay Innovation led, and was joined by La Maison, Top Harvest Capital and insider Obvious Ventures. Link
  • ICU Medical (Nasdaq: ICUI) is partnering with Linden Capital Partners to bid for the patient monitoring and interventions businesses of Medtronic (NYSE: MDT), which could fetch upwards of $9b, per Reuters. Other second-round suitors include Carlyle, Clayton Dubilier & Rice and GE Healthcare. Link

Inverstors raising funds:

  • SR One, a life sciences-focused VC firm, raised $500m for its second independent fund since spinning out of GlaxoSmithKline in 2020. Link

Read the news of digital businesses by email each day at www.multiversial.es